Form 4: Medpace Holdings Exec. VP, Operations, Susan E. Burwig, Acquires 11,017 Shares Via Stock Option

Susan E. Burwig, Executive VP of Operations at Medpace Holdings, Inc., reports the acquisition of 11,017 shares through a stock option grant.

Summary

• Susan E. Burwig, an Executive VP at Medpace Holdings, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on March 6, 2025.
• Burwig acquired 11,017 shares of Medpace Holdings common stock through the exercise of an employee stock option.
• The exercise price of the option was $325.73.
• The option vests immediately upon issuance and expires on March 6, 2034.
• Following the transaction, Burwig directly owns 11,017 derivative securities.
• Burwig also disposed of 65,000 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock option grant and disposal of shares. The sentiment is neutral as it simply reports facts without expressing any opinion or outlook.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.

Negatives

• The disposal of 65,000 shares of common stock by a company executive could be seen as a negative signal.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may interpret the executive's stock option exercise and disposal of shares as a signal of their confidence, or lack thereof, in the company's future prospects.

Key Dates